Atogepant safe, effective to treat chronic migraine: Study

IANS | August 2, 2023 5:46 PM

London, Aug 2 (IANS) Atogepant, a prescription medicine, is safe and effective to treat chronic migraine, which affects more than one billion individuals each year across the world, according to new trial results published in The Lancet.

Fit-tech startup beatXP set to raise $50 mn, say sources

IANS | August 1, 2023 12:56 PM

New Delhi, Aug 1 (IANS) Leading health-tech company Pristyn Care’s direct-to-consumer (D2C) startup beatXP is in advanced talks to raise $50 million from a group of investors, according to the sources close to the development.